To The Moon

Writing about finance since 2016 has taught me a lot. But more importantly, it’s taught me what not to believe. After nearly two decades of personal experience and studying the greats, my investing principles are defined just as much by the myths I reject as the truths I accept. Here are 4 investing illusions I refuse to buy into: ❌ Myth 1: Active Stock Picking Beats the Market The reality? Most stock pickers vastly underperform the broader market. Even Wall Street professionals fail at this consistently—a truth proven from the 1970s all the way to today’s SPIVA reports. The hard truth: If your financial plan requires a magical 15%–20% annualized return to succeed, your portfolio isn't the problem—your capital is. You are trying to build massive wealth with too little seed money. The fix:

​🧠 Pops’ Market Musings: The Illusion of ATHs & Earning "Cognitive Money" ​Whenever the market hits new All-Time Highs (ATHs), retail traders usually default to one of two emotional extremes: 1️⃣ FOMO in and chase the pump. 2️⃣ Assume it’s a bubble and liquidate everything. ​But there’s a rule I always come back to: You can never earn money beyond your cognitive understanding. ​When smart money looks at a market peak, they aren't playing a guessing game of "buy or sell." Instead, they ask: How do we capture the upside while building an unbreakable moat against a sudden drop? ​Retail drifts with the daily price action. Professionals manage risk structure. Here is how they earn their "Cognitive Money": ​🛡️ Level 1: The Armor (Spot & Sector Hedges) ​Amateurs buy and pray. Professional

​📊 Key Market Watch: The Week Ahead (May 25–29) ​✅ Geopolitics & The Commodity Ripple Effect The Middle East remains a wild card. Unresolved US-Iran tensions over uranium enrichment threaten to keep oil and freight rates elevated, which could soon trigger a broader wave of commodity inflation. Although Trump recently hinted at the inevitability of peace talks—underscored by his highly scrutinized absence from his son's wedding this weekend to manage the situation—the geopolitical chessboard will absolutely dominate market sentiment in the week ahead. ​✅ The Defensive Pivot in US Equities Sector rotation is actively reshaping the market. While tech flexed its muscles last week, capital is quietly migrating from the recent energy rally into classic defensive havens: Utilities, Healthcare

​Wall Street is terrified that the AI bubble is about to burst. ​But Gavin Baker (the former Fidelity legend who famously beat 99% of his peers) just dropped a contrarian masterclass on why this cycle is fundamentally different. ​The tl;dr? The brakes of this bull market aren't controlled by the Fed. They are controlled by TSMC. ​If you are trading the AI infrastructure boom, your thesis is dangerously incomplete without these 3 structural realities: ​1️⃣ The Ultimate Anti-Bubble: TSMC’s "Stubborn" Guardrails ​The market's biggest fear is a repeat of the 2000 telecom crash or the 2018 memory glut: supply massively outrunning demand, leading to a catastrophic collapse in pricing. ​Baker’s reality check: That requires unhinged overbuilding. And the only company capable of overbuilding is TSM

Over the last 40 years, Wall Street has maintained a brutal tradition: giving every incoming Federal Reserve Chair a violent "Welcome to the Market" hazing ritual. ​Let’s look at the tape: ​1. Paul Volcker (Aug 1979) ​Backdrop: The U.S. was facing historically terrifying inflation. ​The Hazing: Volcker came in swinging with an iron-fisted, hawkish approach, hiking rates aggressively. From his start in August to November, the S&P 500 dropped ~10%. It was short-term pain, but he eventually slayed the inflation dragon. ​2. Alan Greenspan (Aug 1987) ​Backdrop: An extended bull market with stretched valuations and the rise of algorithmic trading. ​The Hazing: The most brutal baptism of fire in history. Just two months after he took the keys to the money printer, "Black Monday" hit. On Oct 1

Why Do You Only Believe in the Rally After It’s Over? 🚀 ​Your portfolio has flawless fundamentals, yet it's trading sideways. Meanwhile, the hardest-to-value sectors are ripping higher every single day. You finally sell a stock because it’s "too expensive," and it immediately goes parabolic. ​Why do you keep missing the most profitable part of the cycle? ​Here is the brutal truth about how market pricing actually works—and why the smart money is always a step ahead of you. ​1. The Illusion of "Unquantifiable" ​There’s a myth that stocks with no real numbers pump the hardest. The reality? The market doesn't trade the unknown; it trades undervalued certainty. ​When a sector (like AI memory or custom silicon) is supply-constrained, the numbers aren't impossible to calculate—they are just virt

AMD Bleeds 5.7% on Foundry Rumors & Cerebras Hype — Is Sub-$400 the Ultimate Buy Zone or a Value Trap? The semiconductor space just experienced a violent sentiment shock. AMD tumbled 5.7% in the latest session, slicing briefly below the psychological $400 level as a sudden wave of de-risking swept through the sector. Sparked by unexpected Intel-Apple foundry narratives and rising noise around the "Nvidia vs. Cerebras" AI chip battle, funds aggressively trimmed their high-beta tech exposure. But is this a fundamental crack in the AI hardware thesis, or just a mechanical shakeout creating a generational entry point? Let’s break down the noise driving this sub-$400 price action. 1️⃣ The Intel-Apple Foundry Shockwave The immediate catalyst for the sector-wide pullback was the emerging narr

$NVDA at All-Time Highs Into Earnings: Is Blackwell Priced for Perfection or Ready to Shock Wall Street? $NVDA reports its highly anticipated earnings this Wednesday after the bell, and the stakes have literally never been higher. With the stock sitting at absolute all-time highs and data center expectations stretched to historic extremes, this isn't just an earnings report—it's the ultimate test of the global AI hardware thesis. With hyperscaler capex scrutiny and lingering tariff anxieties colliding, the market is bracing for a violent, binary move. Is a "sell-the-news" bloodbath inevitable, or can the Blackwell supercycle melt the market upward once again? Let’s break down the mechanics of Wednesday's print. 1️⃣ The Blackwell Supercycle: Reality vs. Expectations Wall Street knows Blackw

Warsh Takes the Wheel, Tech Bleeds: Is the AI Deleveraging a Trap or a Buy-the-Dip Gift? The Powell era is officially over. With Jerome Powell stepping down on May 15th and Kevin Warsh sworn in as the new Fed Chair, the market reacted exactly how you’d expect during a major regime change: with absolute violence. U.S. equities faced a sharp, broad-based liquidation on Monday, with high-beta tech, AI-photonics, and memory chips taking the brunt of the damage. But this wasn't just a regular red day—under the hood, both hedge funds and asset managers recorded simultaneous net selling, pushing macro short positions to a two-month high. The institutional smart money is actively de-risking. The question for retail now is simple: do you blindly buy this tech dip, or is this the start of a much dee

Hims & Hers Q1 Showdown: Can the Novo Nordisk Partnership Shield HIMS From an FDA Compounding Ban? Hims & Hers ($HIMS) is set to report highly anticipated Q1 2026 earnings tomorrow after the closing bell, riding an explosive +37% monthly rally that completely defied the broader healthcare sector slump. With the FDA aggressively proposing to exclude key weight-loss molecules from its 503B compounding bulks list, retail bears are betting on a catastrophic revenue cliff. Meanwhile, Eli Lilly ($LLY) just surged 10% on a massive earnings beat, leaving traders wondering: is Hims about to follow Lilly to new highs, or are traders walking straight into a regulatory trap? Here is the data-driven breakdown of how the smart money is positioning for the print. 1️⃣ The FDA 503B Proposal & T